Skip to main content

Pharma News

academics

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The virus that causes COVID-19 is widespread in wildlife : Scientists find

    SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to Virginia Tech research published today in Nature Communications. The virus was detected in six common backyard species and antibodies indicating prior exposure to the virus were found in five species with rates of exposure ranging from 40 to 60 percent depending on the species.

  • Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies

    Substituting amines with phosphonium-based cations could greatly improve the performance of mRNA-loaded polymeric micelles, report scientists from Tokyo Tech. By adopting this innovative strategy, they managed to enhance the stability and mRNA-delivery capabilities of micelle nanocarriers into tumor tissue in vivo. Their results hint at the importance of exploring other cations besides amines in mRNA drug delivery and could pave the way to effective treatment for challenging diseases.

  • Another Indian discovered medicine, deuruxolitinib gets FDA approval against baldness
    Indian Pharma giant, Sun Pharma gets the U.S. Food and Drug Administration, FDA approval for LEQSELVI deuruxolitinib 8 mg tablets for the treatment of adults with severe alopecia areata.
  • Large genetic study on severe COVID-19 - Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene
    Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn UKB and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals.
  • Fighting leukaemia by targeting its stem cells
    Acute myeloid leukaemia is one of the deadliest cancers. Leukaemic stem cells responsible for the disease are highly resistant to treatment. A team from the University of Geneva UNIGE, University Hospital of Geneva HUG, and Inserm has made a breakthrough by identifying some of the genetic and energetic characteristics of these stem cells, notably a specific iron utilisation process.
  • IIHMR University Bids Farewell to 334 Graduates at the Annual Convocation
    IIHMR University, a leading health management research university in India, on July 20 th successfully wrapped up its Annual Convocation, at the pristine campus in Jaipur, Rajasthan. The momentous occasion marked a milestone event in the lives of 334 students who were conferred with their well-deserved degrees.
  • Zydus announces non-exclusive patent licensing agreement with Takeda for Vault Vonoprazan in India
    Zydus Lifesciences Limited discovery-driven global lifesciences company has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to market the novel Potassium Competitive Acid Blocker P-CAB Vonoprazan in India.
  • Diabetes Drug Reduces Drug Resistance in Lung Cancer
    A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
  • New gene therapy for muscular dystrophy offers hope
    A new gene therapy treatment for Duchenne muscular dystrophy shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.
  • Supplements slow disease progression during late stage of dry age-related macular degeneration
    In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision. Researchers reviewed the original retinal scans of participants in the Age-Related Eye Diseases Studies (AREDS and AREDS2) and found that
Subscribe to Pharma News